Identification of Novel Small-Molecule Inhibitors of West Nile Virus Infection

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Virology

• Publication date

  2007-08-22

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1128/JVI.01358-07PMID 17715228PMCID PMC2168801
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Viral Translation Is Coupled to Transcription in Sindbis Virus-Infected Cells

  2007cited by this paper
• A Single siRNA Suppresses Fatal Encephalitis Induced by Two Different Flaviviruses

  2006cited by this paper
• Resistance to Alpha/Beta Interferon Is a Determinant of West Nile Virus Replication Fitness and Virulence

  2006cited by this paper
• Inhibition of dengue virus replication by mycophenolic acid and ribavirin.

  2006cited by this paper
• Temporal analyses of the neuropathogenesis of a West Nile virus infection in mice

  2006cited by this paper
• Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters.

  2006cited by this paper
• Triaryl Pyrazoline Compound Inhibits Flavivirus RNA Replication

  2006influential reference
• Discovery of small molecule inhibitors of West Nile virus using a high-throughput sub-genomic replicon screen.

  2006cited by this paper
• Pathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral Evasion

  2006cited by this paper
• Antibodies against West Nile Virus Nonstructural Protein NS1 Prevent Lethal Infection through Fc γ Receptor-Dependent and -Independent Mechanisms

  2006cited by this paper
• Isolation and Characterization of Human Monoclonal Antibodies from Individuals Infected with West Nile Virus

  2006influential reference
• PKR and RNase L Contribute to Protection against Lethal West Nile Virus Infection by Controlling Early Viral Spread in the Periphery and Replication in Neurons

  2006cited by this paper
• Caspase 3-Dependent Cell Death of Neurons Contributes to the Pathogenesis of West Nile Virus Encephalitis

  2006cited by this paper
• Peginterferon and ribavirin for chronic hepatitis C.

  2006cited by this paper
• West Nile virus neuroinvasive disease

  2006cited by this paper
• Antiviral Peptides Targeting the West Nile Virus Envelope Protein

  2006cited by this paper
• Identification of compounds with anti-West Nile Virus activity.

  2006cited by this paper
• Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing.

  2005cited by this paper
• The Predominant Mechanism by Which Ribavirin Exerts Its Antiviral Activity In Vitro against Flaviviruses and Paramyxoviruses Is Mediated by Inhibition of IMP Dehydrogenase

  2005cited by this paper
• West Nile Virus

  2005cited by this paper
• Virology, Pathology, and Clinical Manifestations of West Nile Virus Disease

  2005cited by this paper
• Protective and Therapeutic Capacity of Human Single-Chain Fv-Fc Fusion Proteins against West Nile Virus

  2005influential reference
• Structural basis of West Nile virus neutralization by a therapeutic antibody

  2005cited by this paper
• West Nile Virus Antibodies in Colombian Horses

  2005cited by this paper
• Actively replicating West Nile virus is resistant to cytoplasmic delivery of siRNA

  2005cited by this paper
• Broad-spectrum inhibitor of viruses in the Flaviviridae family.

  2005cited by this paper
• NS1 Protein Secretion during the Acute Phase of West Nile Virus Infection

  2005cited by this paper
• Epidemiology and Transmission Dynamics of West Nile Virus Disease

  2005cited by this paper
• Inhibition of Flavivirus Infections by Antisense Oligomers Specifically Suppressing Viral Translation and RNA Replication

  2005cited by this paper
• Use of RNA interference to prevent lethal murine west nile virus infection.

  2005cited by this paper
• Treatment of West Nile virus-infected mice with reactive immunoglobulin reduces fetal titers and increases dam survival.

  2005cited by this paper
• Inhibition of Interferon Signaling by the New York 99 Strain and Kunjin Subtype of West Nile Virus Involves Blockage of STAT1 and STAT2 Activation by Nonstructural Proteins

  2005cited by this paper
• Peptide inhibitors of dengue virus and West Nile virus infectivity

  2005cited by this paper
• Castanospermine, a Potent Inhibitor of Dengue Virus Infection In Vitro and In Vivo

  2005influential reference
• Inhibition of Alpha/Beta Interferon Signaling by the NS4B Protein of Flaviviruses

  2005cited by this paper
• Dengue Virus Inhibits Alpha Interferon Signaling by Reducing STAT2 Expression

  2005cited by this paper
• Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains.

  2005cited by this paper
• High-Throughput Assays Using a Luciferase-Expressing Replicon, Virus-Like Particles, and Full-Length Virus for West Nile Virus Drug Discovery

  2005cited by this paper
• Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus

  2005influential reference
• Alpha/Beta Interferon Protects against Lethal West Nile Virus Infection by Restricting Cellular Tropism and Enhancing Neuronal Survival

  2005cited by this paper
• Inhibition of Interferon-Stimulated JAK-STAT Signaling by a Tick-Borne Flavivirus and Identification of NS5 as an Interferon Antagonist

  2005cited by this paper
• Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases.

  2005influential reference
• Error-prone replication of West Nile virus caused by ribavirin.

  2005cited by this paper
• Neuronal CXCL10 Directs CD8+ T-Cell Recruitment and Control of West Nile Virus Encephalitis

  2005cited by this paper
• Use of Interferon-α in Patients with West Nile Encephalitis: Report of 2 Cases

  2005cited by this paper
• The Host Response to West Nile Virus Infection Limits Viral Spread through the Activation of the Interferon Regulatory Factor 3 Pathway

  2004cited by this paper
• Calgary Experience with West Nile Virus Neurological Syndrome During the Late Summer of 2003

  2004cited by this paper
• West Nile virus: where are we now?

  2004influential reference
• Analysis of Adaptive Mutations in Kunjin Virus Replicon RNA Reveals a Novel Role for the Flavivirus Nonstructural Protein NS2A in Inhibition of Beta Interferon Promoter-Driven Transcription

  2004cited by this paper
• Effect of Interferon-α2b Therapy on St. Louis Viral Meningoencephalitis: Clinical and Laboratory Results of a Pilot Study

  2004cited by this paper
• Clinical Characteristics of West Nile Fever

  2004cited by this paper
• Genetic and phenotypic variation of West Nile virus in New York, 2000-2003.

  2004cited by this paper
• Combinations of nucleoside/nucleotide analogues for HIV therapy.

  2004cited by this paper
• Blocking of the Alpha Interferon-Induced Jak-Stat Signaling Pathway by Japanese Encephalitis Virus Infection

  2004cited by this paper
• Effect of Interferon-Alpha and Interferon-Inducers on West Nile Virus in Mouse and Hamster Animal Models

  2004cited by this paper
• Neurologic Manifestations and Outcome of West Nile Virus Infection

  2004cited by this paper
• Effect of interferon-alpha2b therapy on St. Louis viral meningoencephalitis: clinical and laboratory results of a pilot study.

  2004influential reference
• Tetracycline-Inducible Packaging Cell Line for Production of Flavivirus Replicon Particles

  2004cited by this paper
• A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication.

  2003influential reference
• Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses.

  2003influential reference
• Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice.

  2003cited by this paper
• B Cells and Antibody Play Critical Roles in the Immediate Defense of Disseminated Infection by West Nile Encephalitis Virus

  2003cited by this paper
• The utility of siRNA transcripts produced by RNA polymerase i in down regulating viral gene expression and replication of negative- and positive-strand RNA viruses.

  2003cited by this paper
• West Nile virus.

  2003cited by this paper
• Antibody Prophylaxis and Therapy against West NileVirus Infection in Wild-Type and ImmunodeficientMice

  2003cited by this paper
• Inhibition of interferon signaling by dengue virus

  2003cited by this paper
• Infection and Injury of Neurons by West NileEncephalitisVirus

  2003cited by this paper
• Efficacy of Interferon α-2b and Ribavirin against West Nile Virus In Vitro

  2002cited by this paper
• Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis

  2002cited by this paper
• Identification of active antiviral compounds against a New York isolate of West Nile virus.

  2002cited by this paper
• High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever.

  2002cited by this paper
• Characterization of Imidazo[4,5-d]Pyridazine Nucleosides as Modulators of Unwinding Reaction Mediated by West Nile Virus Nucleoside Triphosphatase/Helicase: Evidence for Activity on the Level of Substrate and/or Enzyme

  2002cited by this paper
• Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA.

  2002cited by this paper
• Partial genetic characterization of West Nile virus strains, New York State, 2000.

  2001cited by this paper
• Treatment of West Nile virus encephalitis with intravenous immunoglobulin.

  2001cited by this paper
• Clinical characteristics of the West Nile fever outbreak, Israel, 2000.

  2001cited by this paper
• The hepatitis C virus internal ribosome-entry site: a new target for antiviral research.

  2001cited by this paper
• Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism.

  2001cited by this paper
• Infection of Human Cells by Dengue Virus Is Modulated by Different Cell Types and Viral Strains

  2000cited by this paper
• Broad-Spectrum Antiviral Activity of the IMP Dehydrogenase Inhibitor VX-497: a Comparison with Ribavirin and Demonstration of Antiviral Additivity with Alpha Interferon

  2000influential reference
• Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells.

  2000cited by this paper
• The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen

  2000cited by this paper
• Efficient initiation of HCV RNA replication in cell culture.

  2000influential reference
• An Antigen Capture Enzyme-Linked Immunosorbent Assay Reveals High Levels of the Dengue Virus Protein NS1 in the Sera of Infected Patients

  2000cited by this paper
• Modulation of Dengue Virus Infection in Human Cells by Alpha, Beta, and Gamma Interferons

  2000cited by this paper
• Interferon-alpha protects mice against lethal infection with St Louis encephalitis virus delivered by the aerosol and subcutaneous routes.

  1999cited by this paper
• Surgical reconstruction of TMJ.

  1999cited by this paper
• West Nile fever--a reemerging mosquito-borne viral disease in Europe.

  1999cited by this paper
• Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.

  1999cited by this paper
• A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

  1999cited by this paper
• Replication of Subgenomic Hepatitis C Virus Rnas in a Hepatoma Cell Line

  1999influential reference
• Noncytopathic Sindbis virus RNA vectors for heterologous gene expression.

  1998cited by this paper
• New mammalian expression vectors

  1990cited by this paper
• Prophylactic ribavirin treatment of dengue type 1 infection in rhesus monkeys.

  1990cited by this paper
• Product review. New mammalian expression vectors.

  1990cited by this paper
• Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug.

  1989cited by this paper
• Treatment of intracranial dengue virus infections in mice with a lipophilic derivative of ribavirin

  1983cited by this paper
• Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies.

  1982cited by this paper
• A contribution to the morphology of Cercaria longissima Faust, 1924.

  1967cited by this paper
• Antibody response in dengue and dengue hemorrhagic fever.

  1967cited by this paper

• Targeting west nile virus replication by xanthine inhibitors

  2025cites this paper
• Evaluation of Polyphenolic Compounds Common in Greek Medicinal Plants for Their Antioxidant Effects and Antiviral Activity Against Dengue and Yellow Fever Viruses

  2025cites this paper
• West Nile virus - a re-emerging global threat: recent advances in vaccines and drug discovery

  2025cites this paper
• Novel Pyrazino[1,2-a]indole-1,3(2H,4H)-dione Derivatives Targeting the Replication of Flaviviridae Viruses: Structural and Mechanistic Insights

  2024cites this paper
• Generation of host-directed and virus-specific antivirals using targeted protein degradation promoted by small molecules and viral RNA mimics.

  2023cites this paper
• Dengue Virus Replication Is Associated with Catecholamine Biosynthesis and Metabolism in Hepatocytes

  2022cites this paper
• Antiviral Compounds for Blocking Arboviral Transmission in Mosquitoes

  2021cites this paper
• Sulfonamides: Antiviral Strategy for Neglected Tropical Disease Virus

  2020cites this paper
• Motif V regulates energy transduction between the flavivirus NS3 ATPase and RNA-binding cleft

  2019cites this paper
• Motif V acts as a Regulator of Energy Transduction Between the Flavivirus NS3 ATPase and RNA Binding Cleft

  2019cites this paper
• An Immunopharmacoinformatics Approach in Development of Vaccine and Drug Candidates for West Nile Virus

  2018cites this paper
• Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokinetics.

  2017cites this paper
• The Medicinal Chemistry of Dengue Virus.

  2016cites this paper
• The in vitro and in vivo antiviral properties of combined monoterpene alcohols against West Nile virus infection.

  2016cites this paper
• Simplified dengue virus microwell plaque assay using an automated quantification program.

  2016cites this paper
• The Antiviral Properties of Melaleuca alternifolia concentrate (MAC) against West Nile virus

  2015cites this paper
• Flaviviruses: Introduction to Dengue Viruses

  2015cites this paper
• Global Virology I - Identifying and Investigating Viral Diseases

  2015cites this paper
• A Drosophila Toolkit for the Visualization and Quantification of Viral Replication Launched from Transgenic Genomes

  2014cites this paper
• Generation of West Nile Virus Infectious Clones Containing Amino Acid Insertions Between Capsid and Capsid Anchor

  2014cites this paper
• Identification of AP80978, a Novel Small-Molecule Inhibitor of Hepatitis C Virus Replication That Targets NS4B

  2014cites this paper
• A tripeptide (NSK) inhibits Japanese encephalitis virus infection in vitro and in vivo

  2014cites this paper
• West Nile Virus Drug Discovery

  2013cites this paper
• Ten years of dengue drug discovery: progress and prospects.

  2013cites this paper
• Potential Therapeutics Against Flaviviruses

  2012cites this paper
• Identification of a small-molecule inhibitor of dengue virus using a replicon system

  2012cites this paper
• A High-Throughput Screening Assay for the Identification of Flavivirus NS5 Capping Enzyme GTP-Binding Inhibitors

  2011cites this paper
• Dengue virus replicons: production of an interserotypic chimera and cell lines from different species, and establishment of a cell-based fluorescent assay to screen inhibitors, validated by the evaluation of ribavirin's activity.

  2010cites this paper
• Identification of palmatine as an inhibitor of West Nile virus

  2010cites this paper
• Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virus.

  2010cites this paper
• Structure and Function Analysis of Therapeutic Monoclonal Antibodies against Dengue Virus Type 2

  2010cites this paper
• Design, synthesis, and in vitro evaluation of potential West Nile virus protease inhibitors based on the 1-oxo-1,2,3,4-tetrahydroisoquinoline and 1-oxo-1,2-dihydroisoquinoline scaffolds.

  2010cites this paper
• Screening Tools for the Identification of Alphavirus Inhibitors

  2010cites this paper
• A novel cell-based 384-well, label-free assay for discovery of inhibitors of influenza A virus

  2010cites this paper
• Understanding The Roles Of Transcriptional Regulators For The Development Of Natural And Novel Inhibitors Of Listeria Monocytogenes.

  2010cites this paper
• Interactions between neuronal innate immune pattern recognition receptor pathways and neurotropic arboviruses: Host measures, viral countermeasures, and potential therapeutics

  2010cites this paper
• Studies on the inhibition of viral entry of flaviviruses

  2010cites this paper
• Identification of Inhibitors of Yellow Fever Virus Replication Using a Replicon-Based High-Throughput Assay

  2009cites this paper
• Novel Therapeutics Against West Nile Virus

  2009influential citation
• Progress on the development of therapeutics against West Nile virus.

  2009influential citation
• Identification and characterization of inhibitors of West Nile virus.

  2009cites this paper
• NMR study of complexes between low molecular mass inhibitors and the West Nile virus NS2B–NS3 protease

  2009influential citation
• Antiviral Treatment of Flaviviruses

  2009cites this paper
• Design, synthesis, and biological evaluation of antiviral agents targeting flavivirus envelope proteins.

  2008cites this paper
• West Nile virus is neutralized by HOCl-modified human serum albumin that binds to domain III of the viral envelope protein E.

  2008cites this paper
• The flavivirus polymerase as a target for drug discovery.

  2008cites this paper
• Defining the levels of secreted non‐structural protein NS1 after West Nile virus infection in cell culture and mice

  2008cites this paper
• Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysis

  2007cites this paper